Anti-inflammatory effects of ethanolic extract of Antrodia salmonea in the lipopolysaccharide-stimulated RAW246.7 macrophages and the λ-carrageenan-induced paw edema model

Food and Chemical Toxicology

Volumn 50, Issue 5, 2012, Pages 1485-1493

  Huang, Guan Jhong ^a   Pan, Chun Hsu ^a   Liu, Fon Chang ^a,b   Wu, Tian Shung ^a,c   Wu, Chieh Hsi ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Da Chien General Hospital   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Anti inflammation; Antrodia salmonea; Carrageenan; Herbal medicine; Paw edema model

Indexed keywords

ALCOHOL; ANTIINFLAMMATORY AGENT; ANTRODIA SALMONEA EXTRACT; CARRAGEENAN; CYCLOOXYGENASE 2; CYTOKINE; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MALONALDEHYDE; NITRIC OXIDE; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTRODIA; ANTRODIA SALMONEA; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GROWTH INHIBITION; INFLAMMATION; MACROPHAGE ACTIVATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PAW EDEMA; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTRODIA; BLOTTING, WESTERN; CARRAGEENAN; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; EDEMA; ETHANOL; LIPOPOLYSACCHARIDES; MACROPHAGES; MALONDIALDEHYDE; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PLANT EXTRACTS; TUMOR NECROSIS FACTOR-ALPHA;

ANTRODIA SALMONEA;

EID: 84862778716     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.01.041     Document Type: Article

References (51)

1. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
2. Antoniou K., Malamas M., Drosos A.A. Clinical pharmacology of celecoxib, a COX-2 selective inhibitor. Expert Opin. Pharmacother. 2007, 8:1719-1732.
3. Bouma M.G., Jeunhomme T.M., Boyle D.L., Dentener M.A., Voitenok N.N., van den Wildenberg F.A., Buurman W.A. Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors. J. Immunol. 1997, 158:5400-5408.
4. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., Vignola A.M. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 2000, 161:1720-1745.
5. Bowlin T.L., Borcherding D.R., Edwards C.K., McWhinney C.D. Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor-alpha production in vitro and in vivo. Cell Mol. Biol. (Noisy-le-grand) 1997, 43:345-349.
6. Bradley J.R. TNF-mediated inflammatory disease. J. Pathol. 2008, 214:149-160.
7. Chang T.T., Chou W.N. Antrodia cinnamomea reconsidered and A. salmonea sp. nov. on Cunninghamia konishii in Taiwan. Bot. Bull. Acad. Sin. 2004, 45:347-352.
8. Chang C.Y., Lue M.Y., Pan T.M. Determination of adenosine, cordycepin and ergosterol contents in cultivated Antrodia camphorata by HPLC method. J. Food Drug Anal. 2005, 13:338-342.
9. Chang, H.Y., Sheu, M.J., Yang, C.H., Lu, T.C., Chang, Y.S., Peng, W.H., Huang, S.S., Huang, G.J., in press. Analgesic effects and the mechanisms of anti-inflammation of hispolon in mice. Evid. Complement Alternat. Med. doi:10.1093/ecam/nep027.
10. Chaturvedi P. Inhibitory response of Raphanus sativus on lipid peroxidation in albino rats. Evid. Complement Alternat. Med. 2008, 5:55-59.
11. Chen G., Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 2002, 296:1634-1635.
12. Chen Y.S., Pan J.H., Chiang B.H., Lu F.J., Sheen L.Y. Ethanolic extracts of Antrodia cinnamomea mycelia fermented at varied times and scales have differential effects on hepatoma cells and normal primary hepatocytes. J. Food Sci. 2008, 73:H179-185.
13. Christodoulou C., Choy E.H. Joint inflammation and cytokine inhibition in rheumatoid arthritis. Clin. Exp. Med. 2006, 6:13-19.
14. Crofford L.J. COX-1 and COX-2 tissue expression: implications and predictions. J. Rheumatol. Suppl. 1997, 49:15-19.
15. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 1994, 76:5-13.
16. Cuzzocrea S., Zingarelli B., Calapai G., Nava F., Caputi A.P. Zymosan-activated plasma induces paw oedema by nitric oxide and prostaglandin production. Life Sci. 1997, 60:215-220.
17. Dawson J., Sedgwick A.D., Edwards J.C., Lees P. A comparative study of the cellular, exudative and histological responses to carrageenan, dextran and zymosan in the mouse. Int. J. Tissue Reac. 1991, 13:171-185.
18. Flavell R.A. The relationship of inflammation and initiation of autoimmune disease: role of TNF super family members. Curr. Top. Microbiol. Immunol. 2002, 266:1-9.
19. Flohe L., Otting F. Superoxide dismutase assays. Methods Enzymol. 1984, 105:93-104.
20. Hallenbeck J.M., Dutka A.J. Background review and current concepts of reperfusion injury. Arch. Neurol. 1990, 47:1245-1254.
21. Hasko G., Nemeth Z.H., Vizi E.S., Salzman A.L., Szabo C. An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice. Eur. J. Pharmacol. 1998, 358:261-268.
22. James S.L. Role of nitric oxide in parasitic infections. Microbiol. Rev. 1995, 59:533-547.
23. Knowles R.G., Moncada S. Nitric oxide synthases in mammals. Biochem. J. 1994, 298(Pt 2):249-258.
24. Kollias G., Douni E., Kassiotis G., Kontoyiannis D. On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol. Rev. 1999, 169:175-194.
25. Lee J.K., Won J.S., Singh A.K., Singh I. Adenosine kinase inhibitor attenuates the expression of inducible nitric oxide synthase in glial cells. Neuropharmacology 2005, 48:151-160.
26. Lee H.S., Chung H.J., Lee H.W., Jeong L.S., Lee S.K. Suppression of inflammation response by a novel A(3) adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-kappaB signaling. Immunobiology 2011, 216:997-1003.
27. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
28. Liu H., Pope R.M. Phagocytes: mechanisms of inflammation and tissue destruction. Rheum. Dis. Clin. North Am. 2004, 30:19-39.
29. McColl S.R., St-Onge M., Dussault A.A., Laflamme C., Bouchard L., Boulanger J., Pouliot M. Immunomodulatory impact of the A2A adenosine receptor on the profile of chemokines produced by neutrophils. FASEB J. 2006, 20:187-189.
30. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70:158-169.
31. Pan M.H., Lai C.S., Dushenkov S., Ho C.T. Modulation of inflammatory genes by natural dietary bioactive compounds. J. Agric. Food Chem. 2009, 57:4467-4477.
32. Pober J.S., Cotran R.S. Cytokines and endothelial cell biology. Physiol. Rev. 1990, 70:427-451.
33. Rajput S., Wilber A. Roles of inflammation in cancer initiation, progression, and metastasis. Front. Biosci. (Schol Ed.) 2010, 2:176-183.
34. Sajjadi F.G., Takabayashi K., Foster A.C., Domingo R.C., Firestein G.S. Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J. Immunol. 1996, 156:3435-3442.
35. Shen Y.C., Wang Y.H., Chou Y.C., Chen C.F., Lin L.C., Chang T.T., Tien J.H., Chou C.J. Evaluation of the anti-inflammatory activity of zhankuic acids isolated from the fruiting bodies of Antrodia camphorata. Planta Med. 2004, 70:310-314.
36. Shen C.C., Shen Y.C., Wang Y.H., Lin L.C., Don M.J., Liou K.T., Wang W.Y., Hou Y.C., Chang T.T. New lanostanes and naphthoquinones isolated from Antrodia salmonea and their antioxidative burst activity in human leukocytes. Planta Med. 2006, 72:199-203.
37. Shen C.C., Wang Y.H., Chang T.T., Lin L.C., Don M.J., Hou Y.C., Liou K.T., Chang S., Wang W.Y., Ko H.C., Shen Y.C. Anti-inflammatory ergostanes from the basidiomata of Antrodia salmonea. Planta Med. 2007, 73:1208-1213.
38. Spector W.G., Willoughby D.A. The inflammatory response. Bacteriol. Rev. 1963, 27:117-154.
39. Springer R.A. Adhesion receptors of the immune system. Nature 1990, 346:425-434.
40. Sullivan G.W., Rieger J.M., Scheld W.M., Macdonald T.L., Linden J. Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. Br. J. Pharmacol. 2001, 132:1017-1026.
41. Sullivan G.W., Fang G., Linden J., Scheld W.M. A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis. J. Infect. Dis. 2004, 189:1897-1904.
42. Suschek C.V., Schnorr O., Kolb-Bachofen V. The role of iNOS in chronic inflammatory processes in vivo: is it damage-promoting, protective, or active at all?. Curr. Mol. Med. 2004, 4:763-775.
43. Tohda C., Nakayama N., Hatanaka F., Komatsu K. Comparison of anti-inflammatory activities of six curcuma rhizomes: a possible curcuminoid-independent pathway mediated by Curcuma phaeocaulis extract. Evid. Complement Alternat. Med. 2006, 3:255-260.
44. Tracey K.J., Cerami A. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 1993, 9:317-343.
45. Tsai Z.T., Liaw S.L. The Use and the Effect of Ganoderma 1985, Sheng-Yun Publishers, Taichung, pp. 116-117.
46. Wajant H., Pfizenmaier K., Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003, 10:45-65.
47. Wen C.L., Chang C.C., Huang S.S., Kuo C.L., Hsu S.L., Deng J.S., Huang G.J. Anti-inflammatory effects of methanol extract of Antrodia cinnamomea mycelia both in vitro and in vivo. J. Ethnopharmacol. 2011, 137:575-584.
48. Weninger S.C., Yankner B.A. Inflammation and Alzheimer disease: the good, the bad, and the ugly. Nat. Med. 2001, 7:527-528.
49. Wu S.H., Yu Z.H., Dai Y.C., Chen C.T., Su C.H., Chen L.C., Hsu W.C., Hwang G.Y. Taiwanofungus, a polypore new genus. Fung. Sci. 2004, 19:109-116.
50. Wynn T.A., Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin. Liver Dis. 2010, 30:245-257.
51. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.